Newer Nicotine and Tobacco Products: Philip Morris International

This page was last edited on at

Since the early 2000s transnational tobacco companies (TTCs) have developed interests in newer nicotine and tobacco products, including e-cigarettes (also known as electronic delivery systems, or ENDS), heated tobacco products (HTPs), snus and nicotine pouches.
Companies have referred to these types of product as ‘next generation products’ (NGPs) although terminology changes over time.

As the harms from conventional products have become better understood, and tobacco control measures have been put in place, the cigarette market – from which tobacco companies make most of their profits – has started to shrink. To secure the industry’s longer-term future, TTCs have invested in, developed and marketed various newer products, including in low and middle-income countries.1  They are often publicly linked to tobacco companies’ harm reduction strategies and labelled ‘reduced risk’ or ‘modified risk’ products.

There is ongoing scientific and policy debate about the role of these products in tobacco control, with concerns around long term health effects, marketing to youth, and how this diversification may help the industry to build credibility and influence  policy makers.12

It is important to note that, despite increasing investment in these products, the core of the global tobacco industry’s business remains unchanged. Newer products form a small proportion of their revenue, compared to conventional products, and will do so for the foreseeable future.


Like its competitors, Philip Morris International (PMI) has been investing in newer nicotine and tobacco products that, unlike cigarettes, have potential for growth in developed markets.3

In 2016, PMI began marketing its flagship new product IQOS (an HTP) under the catchphrase “this changes everything”, a phrase that was trademarked in 2017.45 In conjunction, PMI began making claims of corporate transformation and commitment to social change focussed on a “smoke-free” future:6

“Society expects us to act responsibly. And we are doing just that by designing a smoke-free future.”7

By October 2019, PMI had replaced the word “designing” with “delivering” (a smoke-free future), signposting the central role of the company in the realisation of this future.89

Despite the promising language in 2016-17,  the majority of the company’s earnings still come from conventional cigarettes.1011 At its 2019 Annual General Meeting, PMI CEO André Calantzopoulos further confirmed to shareholders that “Our combustible tobacco portfolio remains the foundation of our business”.12 During the Covid-19 pandemic, PMI stated that in 2020 its “combustible tobacco portfolio showed resilience”11 and Marlboro cigarettes remain key to PMI’s business model.13 

In May 2017, Vaping Post quoted Calantzopoulos (from an interview with Nikkei Asian Review), saying that in five years’ time (i.e. by 2022) “PMI could start talking to governments about phasing out combustible cigarettes entirely”.14 However, in 2020 PMI’s business is still predominantly focused on the sale of conventional tobacco products. There is evidence of new cigarette brand variants being launched in lower income countries, and conventional tobacco products continue to be vigorously promoted.1516 1718


From 2002, a time of increased tobacco regulation and declining cigarettes sales in Europe, the international tobacco companies started investing in a Swedish smokeless tobacco called snus. 19 The product is sold as a paste or in a tiny pouch, and placed between the gum and lip for a period of time.

PMI was the last of the big international tobacco companies to invest in snus, albeit with little apparent enthusiasm. In October 2006, PMI acquired snus manufacturer Rocker Productions, and briefly sold 1847 by Phillip Morris on the Swedish market.20 Three years later, it sold Rocker Productions to Swedish Match as part of a deal that saw PMI and Swedish Match set up joint venture SMPM International to “globalise snus”.21 The joint venture never achieved commercial success, and in 2015 the two companies “mutually agreed” to dissolve the company.22

Although the other transnational tobacco companies had invested in snus-type products, including nicotine pouches, it was not until late 2019 that PMI expressed an interest. When questioned about the company’s plans at an investment conference, Calantzopoulos conceded that this was “an emerging category….which we are looking at as well”.23 

In May 2021, PMI acquired Danish snus manufacturer AG Snus, which produces tobacco leaf products and nicotine pouches.2425 This acquisition was not widely publicised. See below for information on PMI’s acquisition of Fertin Pharma, which produces other oral nicotine products.

  • For more information about the tobacco industry’s snus investments, including Altria’s interests in tobacco-free nicotine pouches, and product launches by PMI’s competitors, go to Cigarette Companies Investing in Snus.
Image 1: PMI’s IQOS Duo which was launched in September 2019 (screenshot taken from, February 2020)

Heated Tobacco Products

The year before the snus joint venture came to an end, PMI entered the HTP and e-cigarette markets (see below). At the time, CEO Calantzopoulos told the Wall Street Journal that he believed the future was in HTPs.26

PMI’s flagship HTP product, called IQOS (image 1), uses a battery-operated device that heats tobacco sticks called HEETS, which are available in several flavours. They are also sold under cigarette brands Marlboro and Parliament in some countries.11

PMI periodically launches new and updated versions of its products which it tests in various markets, including the Dominican Republic. TEEPS, PMI’s second HTP brand, and ILUMA, PMI’s latest IQOS variant, are currently in development.


Image 2: The IQOS Mesh (screenshot taken from, December 2019)

As with snus, PMI was the last of the international tobacco companies to move into the e-cigarette market. In November 2013, PMI announced that it was going to produce its own e-cigarette.27 By 2019 the company had three e-cigarette brands in its product portfolio, two of which were sold only in the United Kingdom (UK) and Ireland, and the other only in Spain and Israel.

The most recent addition was developed in-house: IQOS Mesh (image 2), the only PMI e-cigarette labelled under the IQOS brand. CEO Calantzopoulos informed investors in December 2019 that Mesh was ready for further commercialisation, but that a global roll-out had been postponed due to the backlash against e-cigarettes following the sudden deaths of a number of vapers in the US.23 In January 2020, the roll-out appeared to be going ahead, with Calantzopoulos announcing “a launch in the coming months”.28 However it was delayed further by the Covid-19 pandemic and finally launched under the Veev brand name in September 2020.291130

Market Expansion and Consolidation

At the beginning of 2020 PMI stated that its “Reduced Risk Products” (RRPs) account for nearly 20% of its net revenue, although it does not disclose publicly the profits from IQOS or other newer products.31 In early 2021 it stated that this figure was nearly 25%11. It continues to expand the sales of its products through independent retailers and IQOS stores. In January 2020, the company reported that it had opened 26 new IQOS stores in South Africa since launching there in 2017.32

Collaboration with KT&G on HTPs and Hybrids

In January 2020, PMI announced a new “collaboration” with South Korean tobacco company KT&G (which dominates the South Korean market), to commercialize KT&G’s range of “smoke-free” products globally, alongside IQOS.28 The deal covered KT&G’s e-cigarettes and HTPs . Although KT&G has a US subsidiary, PMI stated at the time, that there were “no current plans to commercialize KT&G products in the U.S.”2833 

In August 2020, KT&G’s lil SOLID HTP devices and Fiit heated tobacco sticks were launched in Russia, followed by Ukraine three weeks later.2934  It appears that lil SOLID is a rebranded Lil Plus device.35

When announcing its financial results in October 2020, PMI made clear the importance of having KT&G’s products in its product portfolio:

“This means that in both these markets [Russia and Ukraine] we now have HTU brands at three price points within the heat-notburn category: super-premium HEETS Creations/Dimensions, premium HEETS and mid-priced Fiit, all of which present attractive margins.”29

PMI launched KT&G’s lil HYBRID device in Japan in October 2020.36 This device uses as form of tobacco leaf and an e-liquid. While the tobacco contains nicotine, PMI referred to these as “Miix consumables and nicotine-free liquid cartridge”.29 This is likely to be because e-cigarette liquids containing nicotine are banned in Japan.  KT&G stated that its lil Hybrid was a “distinctive platform”. However Japan Tobacco International (JTI) markets a range of hybrid HTPs (for details see Newer Nicotine and Tobacco Products: Japan Tobacco International).  It appears that PMI aims to gain further market share in JTI’s home market, which is already dominated by IQOS.

Undermining Tobacco Control Legislation

Although PMI has been promoting a “smoke-free” narrative, including funding the Foundation for a Smoke-Free World and its “Unsmoke” marketing campaign, it has also been working to undermine smoking bans and enable the use of IQOS in smoke-free areas.37 Just two months after the public smoking ban was introduced in the Czechia (then the Czech Republic) in 2017, PMI promoted IQOS on Radio Praha to Czech smokers. According to the radio station it: “might allow them [smokers] to ‘smoke’ in public places once again”.38

PMI has also been courting the hospitality industry to relax smoking bans by allowing the use of IQOS where smoking is banned.37 Allegedly more than 1,000 hotels around the world were offering “IQOS friendly rooms” in 2018, and “…in some cases, allow the use of smoke-free products in common areas”.39 The UK IQOS website published a list of the “15 Best IQOS Friendly Locations in London”, venues that are “happy to accommodate users of heated tobacco technology”.40 PMI has also promoted “smoke-free islands” in Greece and the Canary Islands.

In January 2020, Calantzopoulos argued that advertising regulations should be relaxed, saying that in the UK it was “difficult to talk to a consumer about a tobacco product” if the product could not be easily seen, which would make it “very difficult to switch”.41 However, although PMI has opened multiple IQOS stores in London, Bristol, Cardiff and Manchester, as an investigation by the Bureau of Investigative Journalist pointed out, as of February 2020 there were none in the UK towns and cities with the highest smoking rates.37

In February 2020, an investigation by The Guardian newspaper revealed that, in the UK, PMI lobbied for lighter regulation of IQOS, as a “considerably less harmful novel smokeless tobacco product” (CLHTP). PMI also proposed setting up a UK£1 billion fund for cessation services in exchange for the relaxation of advertising regulations for e-cigarettes and HTPs.42 It also tried to get IQOS adopted as a cessation product in New Zealand.434445

PMI has also taken advantage of tobacco control measures being implemented in the UK in order to promote its HTPs. In January 2019, PMI promoted  IQOS and new, stronger variants of menthol HEETS sticks in the UK, ahead of the deferred EU Tobacco Products Directive ban on menthol cigarettes (due to come into effect in May 2020).46474849 An “IQOS Menthol starter kit” aimed at convenience stores was available to retailers via a website called “”.4650 Run by Philip Morris Ltd (PML), the website stated that “From 20th May 2020, the only menthol tobacco you can sell is HEETS” (noting that specialist cigars and cigarillos were exempted from the ban). It also contained a claim that “51% of menthol smokers would replace menthol cigarettes with IQOS after the ban”.50

PMI has lobbied to overturn HTP and e-cigarette bans and create a market for its products in Australia.515253  For more details see Heated Tobacco Products.

PMI has also conflated its e-cigarette and HTPs, both now branded as IQOS, which has implications for product regulation and public information.54 For details see IQOS: Use, “switching” and “quitting”.

Acquired Pharmaceutical Companies and NRT-Type Products

In a presentation to investors in February 2021, PMI stated that it planned to go “beyond nicotine” into “botanicals” and “respiratory drug delivery” (image 3).55 It said that this was part of its “long term evolution into a broader lifestyle & consumer wellness company”.55

Screenshot of PMI Beyond Nicotine slide

Image 3: Slide from PMI presentation to investors, 10 February 2021. (Source PMI website)

It is not clear if this strategy includes cannabis products (see below).

Fertin Pharma and Oral Nicotine

In July 2021, PMI announced that it was acquiring Fertin Pharma for around US$820 million.  PMI described the company as “a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems”.56 In a press release CEO Jack Olczak said that the company was a “leading producer of Nicotine Replacement Therapy (NRT) solutions”. PMI referred to these products as “modern oral” and includes nicotine pouches in the same category.56 (The term “modern oral” appears to have been first used by British American Tobacco).

Vectura Inhalers

Also in July 2021, PMI announced its intention to acquire Vectura, a UK company specialising in inhaler products to deliver medicines.5758

Syqe Medical Inhalers

In 2016, PMI bought an Israeli company, Syqe Medical, which was developing a cannabis inhaler.59

TobaccoTactics Resources

Relevant links

TCRG Research

Identifying misleading corporate narratives: The application of linguistic and qualitative methods to commercial determinants of health research, I. Fitzpatrick , A. Bertscher, A.B. Gilmore, PLOS Global Public Health, 16 November 2022, doi:10.1371/journal.pgph.0000379

Tobacco industry messaging around harm: Narrative framing in PMI and BAT press releases and annual reports 2011 to 2021, I. Fitzpatrick, S. Dance, K. Silver, M. Violini, T.R. Hird, Frontiers in Public Health, 18 October 2022, doi:10.3389/fpubh.2022.958354

Transnational tobacco company interests in smokeless tobacco in Europe: Analysis of internal industry documents and contemporary industry materials, S. Peeters, A. Gilmore, PLoS Medicine, 2013,10(9):1001506,  doi:10.1136/tobaccocontrol-2013-051502

Understanding the emergence of the tobacco industry’s use of the term tobacco harm reduction in order to inform public health policy, S. Peeters, A.B. Gilmore, Tobacco Control, 2015; 24:182-189

For a comprehensive list of all TCRG publications, including research that evaluates the impact of public health policy, go to the Bath TCRG’s list of publications.


  1. abSTOP, Addiction At Any Cost: The Truth About Philip Morris International, 20 February 2020, accessed January 2021
  2. S. Peeters, A.B. Gilmore, Understanding the emergence of the tobacco industry’s use of the term harm reduction in order to inform public health policy, Tobacco Control, 2015; 24:182-189, doi:10.1136/tobaccocontrol-2013-051502
  3. Euromonitor International, Global Tobacco Key Findings Part 2: Vapour Products. August 2016 (behind paywall)
  4. Philip Morris International, This Changes Everything: Annual Report 2016, 2017, accessed January 2020
  5. Justia Trademarks, IQOS this changes everything- Trademark details, undated, accessed December 2019
  6. R. Davies, A. Monaghan, Philip Morris’s vision of cigarette-free future met with scepticism, The Guardian, 30 November 2016, accessed September 2017
  7. Philip Morris Products S.A., Delivering a smoke-free future. How long will PMI be in the cigarette business?, PMI website, undated, accessed December 2019
  8. Philip Morris International, Designing a Smoke-Free future, PMI website, archived 30 September 2019, accessed December 2019
  9. Philip Morris International, Delivering a smoke-free future, PMI website, archived 16 October 2019, accessed December 2019
  10. Philip Morris International, 2018 Annual Report, accessed December 2019
  11. abcdePhilip Morris International, 2020 Annual Report, accessed June 2021
  12. L.C. Camilleri, A. Calantzopoulos, Annual Meeting of Shareholders New York 1 May 2019, Philip Morris International, Presentation Script, accessed December 2019
  13. Philip Morris International, Philip Morris International Inc. Reports 2019 Fourth-Quarter & Full-Year Results, PMI press release, 6 February 2020, accessed February 2020
  14. D. Caruana, PMI CEO talks about phasing out cigarettes in Japan & S. Korea, Vaping Post, 18 July 2017, accessed February 2020
  15. Stopping Tobacco Organizations and Profits, Philip Morris International Licensing Marlboro Production in Uzbekistan is More Evidence Its “Unsmoke” Rhetoric Is A Lie, STOP press release, Expose Tobacco website, 5 December 2019, accessed February 2020
  16. Campaign for Tobacco Free Kids, Philip Morris Declares the “Year of Unsmoke,” But Launches New Cigarette in Indonesia and Sells Over 700 Billion Cigarettes a Year Worldwide, PR newswire, 18 April 2019, accessed February 2020
  17. T. Kary, Philip Morris Says It Doesn’t Want You to Buy Its Cigarettes, Bloomberg, 17 April 2019, accessed February 2020
  18. Euromonitor International, Tobacco in Indonesia, July 2020, accessed March 2021 (paywall)
  19. S. Peeters, A. Gilmore, Transnational tobacco company interests in smokeless tobacco in Europe: Analysis of internal industry documents and contemporary industry materials, PLoS Medicine, 2013,10(9):1001506
  20. PMI buys into Swedish Snus, Tobacco Reporter Magazine, December 2006 (paywall)
  21. Swedish Match, Interim Report: January-March 2010, Swedish Match website, accessed December 2019
  22. Swedish Match, Swedish Match and Philip Morris International to dissolve smokeless joint venture, 16 July 2015, accessed December 2019
  23. abA. Calantzopoulos, M. King, Morgan Stanley Global Consumer & Retail Conference Webcast, Philip Morris International, 3 December 2019, accessed December 2019
  24. Mazanti-Andersen, AG Snus Aktieselskab sold to Phillip Morris International, law firm website, 7 May 2020, accessed July 2021
  25. Open Corporates, AG Snus Aktieselskab, Company number 32883044, accessed July 2021
  26. T. Gara, What Do Smokers Really Want: E-Cigarettes, or Safer Tobacco?, The Wall Street Journal, Corporate Intelligence blog, 10 January 2014, accessed February 2020 (paywall)
  27. S. Cavale, D.K. Kumar , Marlboro make Philip Morris to end e-cigarette business, Reuters, 20 November 2013, accessed May 2019
  28. abcPhilip Morris International Inc. Announces Agreement with KT&G to Accelerate the Achievement of a Smoke-Free Future, Business Wire, 28 January 2020, accessed January 2020
  29. abcdPhilip Morris International, 2020 Third quarter results, transcript, 20 October 2020, accessed October 2020
  30. IQOS Veev launch offer, IQOS NZ website, archived 20 September 2020, accessed October 2020
  31. Philip Morris International, 2019 Fourth-Quarter and Full-Year Results, PMI website, 6 February 2020, accessed February 2020
  32. Cigarette and tobacco giant backs South Africa with R650 million investment drive and retail store expansion,, 20 January 2020, accessed January 2020
  33. KT&G, KT&G USA, company website, undated, accessed January 2020
  34. C. Moon-hee, KT&G’s e-Cigarette ‘Lil SOLID’ Goes on Sale in Ukraine, 9 September 2020, accessed November 2020
  35. KT&G, Product Innovation, PDF download available from, accessed November 2020
  36. K. Min-jee, KT&G, Philip Morris to launch sales of e-cigarette ‘lil Hybrid 2.0’ in Japan, 22 October 2020, accessed November 2020
  37. abcM. Davies, B. Stockton, M. Chapman, T. Cave, The ‘UnSmoke’ Screen: The Truth Behind PMI’s Cigarette-Free Future, The Bureau of Investigative Journalism, 24 February 2020, accessed February 2020
  38. D. Lazarova, Czech smokers taking stock of heat-not-burn tobacco products as smoking ban starts to bite’, Radio Praha, 31 July 2017, accessed September 2017
  39. D.Szpytma, PMI Calls On The Travel Industry To Join the Journey Toward a Smoke-Free World,, 7 November 2018, accessed December 2019
  40. Philip Morris Products S.A., Blog: 15 Best IQOS Friendly Locations in London,, 25 June 2018, accessed December 2019
  41. R. Lynch, Philip Morris boss calls for UK tobacco advertising rules to be relaxed, The Telegraph, 21 January 2020, accessed January 2020 (paywall)
  42. S. Bosely, Philip Morris drew up plan for £1bn tobacco transition fund, The Guardian, 24 February 2020, accessed February 2020
  43. G. Espiner, Philip Morris tried to target poor through poverty group and Counties Manukau DHB, 27 August 2019, accessed September 2020
  44. Philip Morris Back to Old Tricks, Hāpai Te Hauora press release, website, 28 August 2019, accessed September 2020
  45. New Zealand Ministry of Health, Letter from Dr Ashley Bloomfield to District Health Board Chief Executives and PHO Chief Executives, PDF available from website, August 2019
  46. abPMI to launch Iqos heated tobacco device in convenience channel,, 2 January 2020, accessed January 2020
  47. Association of Convenience Stores, Menthol Cigarettes Ban, ACS website, 2019, accessed January 2020
  48. Action on Smoking and Health, Tobacco Policy and the European Union, ASH fact sheet, August 2016
  49. European Commission, Directive 2014/40/EU Of The European Parliament And Of The Council, 3 April 2014, accessed January 2020
  50. abPhilip Morris Ltd, IQOS,, undated, accessed January 2020
  51. Stopping Tobacco Organizations and Products, Addiction At Any Cost: The Truth About Philip Morris International, STOP report, 20 February 2020, accessed February 2020
  52. T. Elliott, Big Tobacco’s shadowy new play, The Sydney Morning Herald, 18 May 2019, accessed February 2020
  53. C. Watts, S. Burton, B. Freeman, Creating a market for IQOS: analysis of Philip Morris’ strategy to introduce heated tobacco products to the Australian consumer market, Tobacco Control, Published Online First: 15 November 2020, doi:10.1136/tobaccocontrol-2020-056057
  54. L. Robertson, J. Hoek, K. Silver, PMI New Zealand conflates IQOS heated tobacco products with electronic nicotine delivery systems, Tobacco Control, Published Online First: 19 November 2021. doi: 10.1136/tobaccocontrol-2021-056964
  55. abAndre Calantzopoulos/Philip Morris International, The Next Growth Phase, Investor day presentation, 10 February 2021, accessed July 2021
  56. abPhilip Morris International, Philip Morris International Announces Agreement to Acquire Fertin Pharma, press release, 1 July 2021, accessed July 2021
  57. Vectura, About Vectura, website, undated, accessed July 2021
  58. Philip Morris International, Earnings Release – Qtr 2 2021, press release, accessed July 2021
  59. S. Solomon, Philip Morris investment in Syqe was 2nd-largest 2016 cannabis deal – reportThe Times of Israel, 9 January 2018, accessed July 2021
Go to Homepage